000			02234 a2200565 4500
005			20250516115417.0
264		0	_c20130408
008			201304s 0 0 eng d
022			_a1557-8992
024	7		_a10.1089/cap.2012.2253 _2doi
040			_aNLM _beng _cNLM
100	1		_aPotter, Presenters Ornella
245	0	0	_aOnset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms. _h[electronic resource]
260			_bJournal of child and adolescent psychopharmacology _cOct 2012
300			_a388-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic alpha-Agonists _xadverse effects
650	0	4	_aAntimanic Agents _xadverse effects
650	0	4	_aAntipsychotic Agents _xadverse effects
650	0	4	_aAripiprazole
650	0	4	_aAsthma _xcomplications
650	0	4	_aAttention Deficit Disorder with Hyperactivity _xcomplications
650	0	4	_aCardiovascular Diseases _xchemically induced
650	0	4	_aChest Pain
650	0	4	_aChild
650	0	4	_aDyskinesia, Drug-Induced _xpsychology
650	0	4	_aFamily
650	0	4	_aFemale
650	0	4	_aGuanfacine _xadverse effects
650	0	4	_aHumans
650	0	4	_aLithium Chloride _xadverse effects
650	0	4	_aMale
650	0	4	_aMood Disorders _xcomplications
650	0	4	_aNeuropsychological Tests
650	0	4	_aObesity _xcomplications
650	0	4	_aParoxetine _xadverse effects
650	0	4	_aPiperazines _xadverse effects
650	0	4	_aPolypharmacy
650	0	4	_aPregnancy
650	0	4	_aPrenatal Exposure Delayed Effects
650	0	4	_aPsychomotor Agitation _xdrug therapy
650	0	4	_aQuinolones _xadverse effects
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xadverse effects
650	0	4	_aSmoking _xadverse effects
650	0	4	_aSocial Environment
700	1		_aJohn, Nadyah
700	1		_aCoffey, Discussant Barbara J
773	0		_tJournal of child and adolescent psychopharmacology _gvol. 22 _gno. 5 _gp. 388-92
856	4	0	_uhttps://doi.org/10.1089/cap.2012.2253 _zAvailable from publisher's website
999			_c22198393 _d22198393